Cecilie Abildgaard
Impact in
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Melanoma and MAPK Pathways
- Circular RNAs in diseases
- RNA modifications and cancer
Papers in
-
- Melanoma and MAPK Pathways 3
- Histone Deacetylase Inhibitors Research 2
- Circular RNAs in diseases 2
-
- Cancer-related molecular mechanisms research 3
- MicroRNA in disease regulation 2
- Co-authors
- Per Guldberg (7 shared papers)Christina Dahl (6 shared papers)Sílvia Regina Rogatto (7 shared papers)Luísa Matos do Canto (6 shared papers)Ingolf F. Nes (1 shared paper)Morten Skaugen (1 shared paper)Karina Dahl Steffensen (3 shared papers)Jiří Bártek (1 shared paper)
- Journals
- Oncotarget (2 papers)Journal of Clinical Oncology (2 papers)Cancers (2 papers)Trends in Molecular Medicine (1 paper)Journal of Experimental & Clinical Cancer Research (1 paper)
- Partner nations
- DenmarkBrazilUnited States
In The Last Decade
Cecilie Abildgaard
17 papers receiving 591 citations
Peers
Comparison fields: 5 of 81
- Cancer Research 194
- Molecular Biology 402
- Oncology 127
- Geriatrics and Gerontology 16
- Immunology 62
Countries citing papers authored by Cecilie Abildgaard
This map shows the geographic impact of Cecilie Abildgaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cecilie Abildgaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cecilie Abildgaard more than expected).
Fields of papers citing papers by Cecilie Abildgaard
This network shows the impact of papers produced by Cecilie Abildgaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cecilie Abildgaard. The network helps show where Cecilie Abildgaard may publish in the future.
Co-authors
The 25 scholars most cited alongside Cecilie Abildgaard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 158 | |
| 2 | 2015 | 100 | |
| 3 | 1997 | 64 | |
| 4 | 2020 | 42 | |
| 5 | 2014 | 41 | |
| 6 | 2023 | 38 | |
| 7 | 2014 | 36 | |
| 8 | 2022 | 36 | |
| 9 | 2018 | 30 | |
| 10 | 2021 | 14 | |
| 11 | 2022 | 13 | |
| 12 | 2017 | 13 | |
| 13 | 2020 | 8 | |
| 14 | 2019 | 4 | |
| 15 | 2024 | 3 | |
| 16 | 2021 | 2 | |
| 17 | 2024 | 1 |
About Cecilie Abildgaard
Cecilie Abildgaard is a scholar working on Molecular Biology, Cancer Research, Oncology, Biotechnology and Immunology, having authored 17 papers that have together received 603 indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (3 papers), Cancer Research and Treatments (3 papers), Cancer-related molecular mechanisms research (3 papers), Cutaneous Melanoma Detection and Management (2 papers), Histone Deacetylase Inhibitors Research (2 papers), Circular RNAs in diseases (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and MicroRNA in disease regulation (2 papers). The work is most often cited by research in Cancer Research (194 citations), Molecular Biology (402 citations), Oncology (127 citations), Geriatrics and Gerontology (16 citations) and Immunology (62 citations). Cecilie Abildgaard has collaborated with scholars based in Denmark, Brazil and United States. Frequent co-authors include Per Guldberg, Christina Dahl, Sílvia Regina Rogatto, Luísa Matos do Canto, Ingolf F. Nes, Morten Skaugen, Karina Dahl Steffensen, Jiří Bártek, S. Moein Moghimi and Per Bo Jensen. Their work appears in journals such as Oncotarget, Journal of Clinical Oncology, Cancers, Trends in Molecular Medicine and Journal of Experimental & Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.